IDEXX Laboratories Acquires CoVet AI as 24 Hour Vet Teams Face Documentation Overload
Executive Summary. IDEXX Laboratories (Nasdaq: IDXX), the veterinary diagnostics group headquartered in Westbrook, Maine, announced on 16 September 2026 the acquisition of CoVetAI Inc. (“CoVet”), an AI-native ambient listening and clinical workflow software provider for veterinary practices. Financial terms were not disclosed. The acquisition links AI documentation directly to the IDEXX software and diagnostics ecosystem used by more than 10,000 clinics globally, and marks the company’s most direct step so far into practice workflow automation.
Key Facts
- Company
- IDEXX Laboratories, Inc. (Nasdaq: IDXX), Westbrook, Maine, USA
- Acquired
- CoVetAI Inc. (“CoVet”), AI-native ambient listening and clinical workflow software
- Announced
- Wednesday, 16 September 2026
- Deal size
- Not disclosed
- Category
- Veterinary software, AI scribes, practice workflow
- Reach
- IDEXX cloud practice management: 10,000+ clinics worldwide; CoVet: tens of thousands of users across North America, Europe, Australia and New Zealand
- Source
- IDEXX investor relations press release (Business Wire)
What Happened
IDEXX said on 16 September 2026 that it had bought CoVet, a rapidly growing provider of AI-native ambient listening and clinical workflow software. CoVet captures and organizes information across the patient care journey, from consultation to treatment planning and client follow-up, and automates SOAP notes and consultation transcription. IDEXX president and CEO Mike Erickson said veterinary practices are managing growing complexity and need better ways to capture, connect and use information, and that CoVet’s workflow intelligence complements the company’s diagnostics and software ecosystem. CoVet co-founder and CEO Yannick Bloem said the company started with clinical documentation and that AI can change the day-to-day experience of practicing veterinary medicine.
The software will be integrated into the IDEXX ecosystem, including VetConnect PLUS, while IDEXX stated it will continue to support other ambient scribe solutions and third-party integrations, and CoVet will keep integrating with non-IDEXX practice management systems.
Background
IDEXX is the largest name in veterinary diagnostics, with in-house products including the IDEXX inVue Dx Cellular Analyzer, SediVue Dx urine sediment analyzer, ProCyte One hematology analyzer, DecisionIQ decision support and Web PACS imaging software, plus the Vello client engagement platform. The company employs roughly 11,000 people and sells in more than 175 countries, and it reports that more than 10,000 clinics run its cloud-based practice management systems. CoVet was built by veterinary professionals for veterinary teams and is used by both independent practices and multi-site corporate groups across North America, Europe, Australia and New Zealand.
Industry Context
The deal lands in a veterinary market where staffing pressure and administrative workload have become the main limits on appointment capacity. Documentation is a core driver: clinical teams routinely spend hours per day writing records. That constraint is most visible where demand never stops, from emergency hospitals and 24 hour vet services to after-hours rosters, where every recovered minute of admin time translates into another appointment slot.
It also reaches smaller formats. Owners searching for a mobile vet near me, or for niche services from an exotic vet near me to feline-only clinics, are effectively competing for the same scarce clinical hours. Independent and mobile practices run lean teams, so AI scribes that cut after-consult paperwork can shorten waiting lists without adding headcount. IDEXX’s own framing, that workflow tools can help practices “see more patients”, makes capacity the explicit commercial goal.
Market & Business Impact
Strategically, the acquisition gives IDEXX an instant distribution channel for workflow AI: the 10,000+ clinics already on its practice management software. IDEXX said combining CoVet with its diagnostics, decision support and Vello engagement tools creates opportunities to connect patient information before, during and after the clinical visit, and to raise diagnostic utilization by surfacing relevant insights at decision points. For competing practice-management vendors and standalone AI scribe startups, the deal raises the bar: diagnostics, records and now ambient AI are being bundled into a single procurement decision. Corporate groups negotiating 2026 software contracts will notice that one vendor can now cover all three layers.
Companies & Brands Involved
The transaction links IDEXX Laboratories, the S&P 500 diagnostics group, with CoVet, one of the ambient AI scribe tools veterinary teams already use in production. Buyers comparing suppliers in the wider pet care market can browse the GlobalPetIndex company directory, which lists manufacturers, wholesalers and service companies across the veterinary supply chain.
Data & Evidence
Financial terms of the transaction were not disclosed, so deal valuation cannot be verified. Verifiable figures from the announcement: IDEXX software is used in more than 10,000 clinics globally; IDEXX employs approximately 11,000 people and sells in more than 175 countries and territories; CoVet serves tens of thousands of users across North America, Europe, Australia and New Zealand. RTTNews reported that IDEXX shares closed Tuesday’s trading, 15 September 2026, 0.23 percent higher at US$510.73 on the Nasdaq, the session before the announcement.
What This Means for the Pet Industry
The veterinary technology market has crossed a line: the workflow layer, not the microscope, is now where practice economics are decided. IDEXX buying CoVet means AI documentation will be bundled with diagnostics and records for thousands of clinics, and independent practices will be asked to choose ecosystems rather than single products. Suppliers to vet clinics, from consumables to software, should expect procurement conversations in 2027 to start with the platform question first.
Key Takeaways
- IDEXX Laboratories announced on 16 September 2026 that it acquired CoVetAI Inc., an AI-native ambient listening and clinical workflow software provider for veterinary practices; financial terms were not disclosed.
- CoVet automates SOAP notes, consultation transcription and client follow-up, and will be integrated into the IDEXX software ecosystem while retaining support for non-IDEXX practice management systems.
- IDEXX reports more than 10,000 clinics on its cloud practice management software, giving the acquired AI tools an immediate global distribution channel.
- The deal signals that practice workflow automation, staff time recovery and diagnostic utilization, not hardware alone, will drive veterinary supplier competition through 2027.
Frequently Asked Questions
What happened?
IDEXX Laboratories acquired CoVetAI Inc. (CoVet), a provider of AI-native ambient listening and clinical workflow software for veterinary practices. The announcement was made on 16 September 2026 and financial terms were not disclosed.
Who is CoVet?
CoVet is an AI-powered clinical copilot built by veterinary professionals. It automates SOAP notes, transcribes consultations and streamlines owner communication, and is used by tens of thousands of veterinary team members across North America, Europe, Australia and New Zealand.
How does this affect appointment availability?
IDEXX’s stated goal is to recover clinician time and create capacity to see more patients. For pet owners, that matters most where demand is continuous, such as emergency and 24 hour vet hospitals, because documentation time is a direct constraint on how many animals a team can treat per shift.
Will smaller or mobile practices benefit?
IDEXX says CoVet serves both corporate groups and independent practices. Mobile and niche operators, the kind owners find by searching a mobile vet near me, typically run the leanest teams, so cutting after-consult paperwork has a proportionally larger effect on their daily capacity.
What should clinics expect next?
IDEXX stated that CoVet will be integrated with its VetConnect PLUS ecosystem and will continue to integrate with non-IDEXX practice management systems. Clinics can expect bundled workflow and diagnostics offerings as contracts come up for renewal through 2027.
Sources
- Primary — IDEXX Laboratories investor relations press release (Business Wire), 16 September 2026
- Secondary — RTTNews, “IDEXX Buys CoVetAI To Expand Veterinary Workflow Intelligence”, 16 September 2026
